Trump Names NIH Director Dr. Jay Bhattacharya as Acting CDC Director
Former head Jim O’Neill has been tapped to lead the National Science Foundation.
It looks like Secretary of State Marco Rubio will not be the only member of the Trump administration who is multitasking.
Jay Bhattacharya, director of the National Institutes of Health (NIH), has been tapped to become the acting director of the Centers for Disease Control and Prevention (CDC) after the exit of former head Jim O’Neill.
The move appears to be part of personnel reshuffling ahead of the midterms.
Jay Bhattacharya, the head of the National Institutes of Health, will become acting director of the Centers for Disease Control and Prevention following the dismissal last week of Jim O’Neill, according to a White House official and an administration official.
President Donald Trump will name O’Neill to lead the National Science Foundation, one of the officials said.
O’Neill, who was also deputy secretary of the Health and Human Services Department, was removed by HHS Secretary Robert F. Kennedy Jr. as part of a broader restructuring that elevated Chris Klomp, deputy administrator of the Centers for Medicare and Medicaid Services, to chief counselor in charge of overseeing all HHS operations.
Administration officials framed last week’s restructuring as a way to “muscle up” ahead of a midterm elections cycle that will focus heavily on the Trump administration’s health policy moves, including a push to lower drug prices, which Klomp has overseen.
White House taps Jay Bhattacharya, CDC critic, to lead agency for now https://t.co/nnwZT0Utor
— David Alexander (@davidalexander5) February 18, 2026
Bhattacharya will also continue to lead the NIH until another candidate is chosen and approved by the U.S. Senate.
Bhattacharya, a former Stanford Medicine professor, gained notoriety during the Covid pandemic for his opposition to lockdowns. He has led the NIH since April.
As director of the world’s largest public funder of biomedical research, Bhattacharya has prioritized research on some of Kennedy’s areas of interest, including chronic disease and nutrition. He has also encouraged scientists to pursue “high-risk, high-reward ideas” and called for more replication of studies to validate their results.Dr. Bhattacharya will continue to run the N.I.H., according to the officials, who insisted on anonymity to speak about personnel decisions before President Trump announces them. He will serve until Mr. Trump appoints a permanent director — a position that now requires confirmation by the Senate.
While he has headed the NIH, perhaps Bhattacharya’s most significant move has been to cut off the use of foreign subcontracts on NIH grants, forcing foreign partners to contract directly with NIH and effectively ending non‑competing continuations for existing awards that rely on foreign subawardees.
The National Institutes of Health will no longer allow American scientists to direct its funding to research partners overseas, casting doubt on the future of studies on subjects including malaria and childhood cancer.
“If you can’t clearly justify why you are doing something overseas, as in it can’t possibly be done anywhere else and it benefits the American people,” Dr. Memoli wrote, “then the project should be closed down.”
The new restrictions, which will apply to domestic subawards as well in the future, come amid deep reductions in N.I.H. funding and the freezing of federal grants at many top universities, along with executive orders seeking to reshape the nation’s scientific agenda.
As a reminder, the Wuhan Institute of Virology (WIV) was such a foreign subawardee. It worked under EcoHealth Alliance’s NIH grant “Understanding the Risk of Bat Coronavirus Emergence”.
To be fair, though… we all now understand those risks in ways we could not have possibly imagined in 2019.
Bhattacharya’s energy and professionalism should serve the CDC well until another director is appointed. Hopefully, he will steady the helm as the administration sails into a politically-charged midterm-season waters.
His record suggests an emphasis on independence and accountability, which may both benefit the NIH and the CDC as they navigate constrained budgets, new approaches to science, and public expectations related to Making America Healthy Again.
Rubio should be grateful that he isn’t being asked to wear another hat!
I would also like to note O’Neill approved a major overhaul of the childhood vaccine schedule and backed limiting covid vaccine recommendations to narrower risk groups rather than universal use, a break from prior CDC guidance. So I am looking forward to see what he does at the NFS.
White House officials confirm to the Washington Examiner that Jim O'Neill will be nominated to lead the NSF! https://t.co/PrE1ATd0bq pic.twitter.com/3E9Pn7dyCi
— Sebastian Caliri (@SebastianCaliri) February 18, 2026
Given O’Neill’s 2023 post, I think he has his work cut out for him.
Science is whatever NSF funds, including robot metaphor police. https://t.co/GNpOJUQtsA
— Jim O’Neill (@regardthefrost) January 5, 2023
Donations tax deductible
to the full extent allowed by law.
Comments
To be fair, though… we all now understand those risks in ways we could not have possibly imagined in 2019.
——-
Hmm, didn’t take a rocket scientist to see funding a CHINESE GAME OF FUNCTION program would not be in. The best Interest of humanity
Temporary good news, but good news, nonetheless. We all want a deeper bench for Trump to do his job – not one spread thinner, but that would require a GOP Senate actually interested in WINNING by crushing our enemies, see them driven before us, and hear the lamentations of their women.
Instead, we have a gaggle of crap weasels slow walking all confirmations in hopes of running out the clock on Trump before the midterms so the GOP can assume their natural position of flaccid cucks in the corner watching the dems wield power.
I’m looking at YOU, John Thune! – chief of the crap weasels. Good grief.
Well done, Mr. President.
but how do we stop the spread of mamdami in this country as commuistnazi agenda grows ….from nyc to ca to oregon to texas
that jasmine crook can win in texas
and if the vote counters arent watched
she will
She’s not winning
Good man, good choice.
Excellent choice. I watched numerous videos of Jay’s out of Stanford concerning COVID and the vaccine. He is the main reason for me not to get the vax until further testing had been done to answer the questions about adverse reactions/deaths from the shot. I never did get the shot.